![FDA approves Fiasp® for use in insulin infusion pumps for adults with type 1 or type 2 diabetes - Rx Management Group FDA approves Fiasp® for use in insulin infusion pumps for adults with type 1 or type 2 diabetes - Rx Management Group](https://www.rapidactinginsulin.com/content/dam/diabetes-patient/rapidactinginsulin/fiasp/Fiasp_home_pen_vial.png.img.png)
FDA approves Fiasp® for use in insulin infusion pumps for adults with type 1 or type 2 diabetes - Rx Management Group
![Efficacy and safety comparison between U-100 human regular insulin and rapid acting insulin when delivered by V-Go insulin delivery device in an older type 2 diabetes - Virtual Meeting | EASD Efficacy and safety comparison between U-100 human regular insulin and rapid acting insulin when delivered by V-Go insulin delivery device in an older type 2 diabetes - Virtual Meeting | EASD](https://cf.easd.org/data/easd/data/talks/1059_718772_1/Slide1.jpg)
Efficacy and safety comparison between U-100 human regular insulin and rapid acting insulin when delivered by V-Go insulin delivery device in an older type 2 diabetes - Virtual Meeting | EASD
![Novo Nordisk's Fiasp (insulin aspart injection) Receives the FDA's Approval for use in Insulin Infusion Pumps to Treat Type 1 or Type 2 Diabetes | PharmaShots Novo Nordisk's Fiasp (insulin aspart injection) Receives the FDA's Approval for use in Insulin Infusion Pumps to Treat Type 1 or Type 2 Diabetes | PharmaShots](https://pharmashots.com/wp-content/uploads/2019/10/Fiasp-850x560.jpg)
Novo Nordisk's Fiasp (insulin aspart injection) Receives the FDA's Approval for use in Insulin Infusion Pumps to Treat Type 1 or Type 2 Diabetes | PharmaShots
![NOVO NORDISK: FDA approves Fiasp® for use in insulin infusion pumps for adults with type 1 or type 2 diabetes | FDA Health News NOVO NORDISK: FDA approves Fiasp® for use in insulin infusion pumps for adults with type 1 or type 2 diabetes | FDA Health News](https://s3.amazonaws.com/jnswire/jns-media/da/0a/4455260/Fiasp.png)
NOVO NORDISK: FDA approves Fiasp® for use in insulin infusion pumps for adults with type 1 or type 2 diabetes | FDA Health News
![PDF) Investigation of Pump Compatibility of Fast-Acting Insulin Aspart in Subjects With Type 1 Diabetes PDF) Investigation of Pump Compatibility of Fast-Acting Insulin Aspart in Subjects With Type 1 Diabetes](https://i1.rgstatic.net/publication/319897192_Investigation_of_Pump_Compatibility_of_Fast-Acting_Insulin_Aspart_in_Subjects_With_Type_1_Diabetes/links/5a310b8a0f7e9b0d50f9312c/largepreview.png)
PDF) Investigation of Pump Compatibility of Fast-Acting Insulin Aspart in Subjects With Type 1 Diabetes
![Insulin pump treatment compared with multiple daily injections for treatment of type 2 diabetes (OpT2mise): a randomised open-label controlled trial - The Lancet Insulin pump treatment compared with multiple daily injections for treatment of type 2 diabetes (OpT2mise): a randomised open-label controlled trial - The Lancet](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/62f21091-22ef-4f34-b413-20ded9637885/gr1.gif)